C5 Biomedical CEO Tim Maye Among 50 Honorees Marking AATB's 50th Anniversary
C5 Biomedical LLC CEO Tim Maye has been named one of 50 honorees by the Association of Advancement of Blood & Tissue (AATB) as the organization celebrates its 50th anniversary.
Tim Maye, CEO of C5 Biomedical LLC, has been recognized as one of 50 distinguished individuals by the Association of Advancement of Blood & Tissue (AATB) during the organization's 50th anniversary celebration. The recognition acknowledges Maye's contributions to the blood and tissue industry.
Maye, who holds the CTBS certification, has dedicated nearly three decades to the field. He has also served as the chair of AATB's Standards Committee for six years, highlighting his role in shaping industry standards and quality.
C5 Biomedical LLC is an FDA-registered and AATB-accredited manufacturer of amniotic membrane allografts, focused on providing tissue-based therapies for clinical applications.
This honor underscores Maye's long-standing commitment and expertise in the field of tissue allografts and his influence on the development of AATB's standards.